Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Metabolic and Epigenetic Orchestration of (Car) T Cell Fate and Function Publisher Pubmed



Akbari B1 ; Hosseini Z2 ; Shahabinejad P3 ; Ghassemi S4, 5 ; Mirzaei HR1 ; Oconnor RS4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pediatrics, Hazrat-e Ali Asghar Pediatrics Hospital, Iran University of Medical Sciences, Tehran, Iran
  3. 3. School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, United States
  5. 5. Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States

Source: Cancer Letters Published:2022


Abstract

Longevity, functionality, and metabolic fitness are key determinants of chimeric antigen receptor (CAR) T cell efficacy. Activated T cells follow an ordered differentiation program which is facilitated by metabolic adaptations. In response to antigen, T cells undergo a highly-regulated shift to glycolysis. Committing to, and engaging in, glycolysis supports T cell expansion and effector function. Inside tumors, heightened tumor cell metabolism and dysregulated perfusion create a competition for nutrients. As local metabolism supports the differentiation of T cells into functionally-competent progeny, nutrient depletion coupled with persisting antigen can trigger T cell exhaustion. Emerging insights into the barriers impeding CAR T cell function in hostile tumor microenvironments (TME) reveal that metabolic intermediates shape the immune response by influencing epigenetic programs and the control of gene expression. In this review, we discuss recent progress connecting cellular metabolism with epigenetic states in CAR T cells. Given that CAR T cell metabolism can be dynamically regulated, we introduce the concepts of “metabolic-based epigenetic altering” and “epigenetic-based metabolism altering” to restore functional competence in CARTs traversing solid TMEs. © 2022 Elsevier B.V.
Other Related Docs
14. Linking Diet and Gut Microbiota in Multiple Sclerosis, Diet and Nutrition in Neurological Disorders (2023)
16. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
17. Tumor Immunology, Clinical Immunology (2022)
18. The Interplay Between Gut Microbiota and Autism Spectrum Disorders: A Focus on Immunological Pathways, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021)
19. Glycolysis and Autoimmune Diseases: A Growing Relationship, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology (2020)
21. Crispr/Cas9 Revitalizes Adoptive T-Cell Therapy for Cancer Immunotherapy, Journal of Experimental and Clinical Cancer Research (2021)
28. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)